https://www.selleckchem.com/pr....oducts/Rosuvastatin-
There is limited research comparing demographic and clinical characteristics between patients who present with atrial fibrillation (AF) and new-onset cardiomyopathy (CM) to patients with new-onset CM without dysrhythmia. We aimed to evaluate clinical characteristics and outcomes in patients with new-onset CM with and without AF and to report their real-world treatment. The study population was identified using patient records from our healthcare system from January 1, 2012 to September 30, 2016. Patients with a lef
Like
Comment
Share
